Shepherd, Finkelman, Miller & Shah, LLP
Shepherd, Finkelman, Miller & Shah, LLP
866-540-5505 877-891-9880

Dedicated Client Advocacy

Consumer Fraud Archives

Please dim those lights: national bank under a withering glare

When asked to name a financial institution that has had a flatly awful past year from a publicity and consumer trust standpoint, it wouldn't be too surprising to see a poll of respondents come up with Wells Fargo, would it?

What's the number one consumer complaint in the U.S.?

While most of us would like to imagine that the goods or services we purchase will be hassle-free, we know from firsthand experience that this is not always the reality. Indeed, products don't always function as advertised, service agreements aren't always honored and items received aren't always the items ordered.

New rule announced in response to consumer fraud, but will it last?

Class-action lawsuits have "been turned upside down" by the arrival of a long-awaited federal bill that many proponents hope will give little-guy plaintiffs more power and meaningful victories against large and obviously better-heeled business interests.

Class: B of A Denied HAMP Modifications for Wronged Homeowners

A federal consumer fraud class action was recently filed against Bank of America, accusing the bank of fraud and unfair business practices. The class claims that, far from working to help desperate homeowners through the HAMP mortgage modification program, the banking giant worked to extract fees from them while scheming to take their homes anyway.

Proposed Class Demands Docs in Namenda Antitrust Suit

The high costs of health care is a major issue in the U.S., which was highlighted in 2015 when Turing Pharmaceuticals notoriously increased the price of the drug that is used as the standard of care for treating a life-threatening parasitic infection from $13 to $750 overnight. When drug companies monopolize a drug through patents, it makes it extremely hard to maintain affordable prices, which becomes particularly unjust when dealing with people's health. Luckily, antitrust laws can help remedy this effect of monopolized drugs.

Feds intervene in health care fraud whistleblower lawsuits

What do you do if you are a billing employee for a health care entity in Connecticut or elsewhere -- a doctor's office, say, or a hospital, clinic, pharmacy, medical device maker, pharmaceutical manufacturer or other participant -- and you note an incongruity between a product or services code and what a patient or other party actually received?